can semaglutide cause pots You Overdose on Semaglutide? Signs, Risks, and What to Do A newly published case series

Efficacy of Weight-loss A recent systematic review and a meta-analysis by Wong et al (2025) found that GLP-1 receptor agonists induced an additional 4.45 kilogram of weight loss over placebo based on 47 randomized control trials with a cohort of 23,244 patients

Among the remaining subjects, we further excluded those who received a diagnosis of bipolar disorder during the follow-up assessment (n = 9), those with missing metabolite data due to the lack of blood samples (n = 158) and those who did not complete the Inventory for Depressive Symptoms questionnaire (n = 33)

Suitable for individuals who need a less intensive, off-label weight management option

Caveolin-1 inhibits expression of antioxidant enzymes through direct interaction with nuclear erythroid 2 p45-related factor-2 (Nrf2)

A GLP1 prescription could indicate: Well-controlled type 2 diabetes Severe obesity under active treatment Metabolic dysfunction associated steatohepatitis (MASH) Obstructive sleep apnea Elevated cardiovascular risk Chronic kidney disease Clinically, those are very different scenarios with very different mortality implications

While some users report feeling more sustained energy within the first two weeks, more noticeable changes in body composition and weight often appear after about 12 weeks of consistent use